Pierre Fabre Medicament

Other

Thien Nguyen Ngoc

Hans Binz

Mathias Uhlen

Stefan Stahl

Nathalie Corvaia

Alain Beck

Thierry Baussant

Christine Andreoni

Hélène Plotnicky

Jean-Fran&ccedil;ois Haeuw

Per Ake Nygren

The invention concerns novel immunogenic peptides derived from the RSV G protein of the sub-group A or B comprising at least: a first peptide derived from the BRSV G protein of sub-group A or B including at least in position 173, 176, 182 and 186 a cysteine and whereof the C-terminal end includes at most the amino acid in position 192; and a second peptide derived from the RSV protein of sub-group A or B, said second peptide being located downstream of said first protein, so that the immunogenic peptide produced has a disulphide bond linking residues 173 and 186 and a second disulphide bond linking residues 176 and 182.

Peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine

The invention relates to an adjuvant product which is intended to improve the activity of a molecule when administered to a host, characterized in that it comprises at least one part of the P40 protein of or a protein having at least 80% homology with the P40 protein of The invention also relates to nucleotide sequences which encode these peptides or proteins and to the use of these sequences as a medicament. More particularly, such DNA sequences can be used in compositions which are intended for immunization by the intramuscular or intradermal route.

Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine

Method for enhancing the immunogenicity of an immunogenic compound or

Method for obtaining a peptide derived from the respiratory syncytial

Growing community of inventors

St. Julien En Genevois, France

Thien Nguyen Ngoc